COMT Protein Assay via Novel Epitope ELISA
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assaying catechol-O-methyltransferase (COMT) protein levels are labor-intensive, time-consuming, and limited in sample handling capacity, posing health risks due to the use of neurotoxic and lung-irritant chemicals, and are not suitable for efficiently screening large numbers of chemicals for endocrine disrupting potential.
Innovation Solution
A novel enzyme-linked immunosorbent assay (ELISA) method using a unique 18-amino acid peptide sequence (Novel Epitope, NE) as a tag for protein detection, with specific antibodies and a kit format that allows for simple, accurate, and rapid measurement of COMT protein levels in biological and environmental samples, reducing health risks and increasing sample handling capacity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If SDS-PAGE/Western blotting is used to assay COMT protein concentration, then measurement precision is improved, but device complexity increases and productivity decreases
Solution Approach 1:
The patent replaces the mechanical/electrophoretic system of SDS-PAGE with an immunological system using enzyme-linked immunosorbent assay (ELISA). The ELISA method uses antibody-antigen binding and enzymatic color development to quantify COMT protein, eliminating the need for gel electrophoresis, Western blots, and hazardous chemicals like acrylamide and SDS. This substitution maintains measurement precision while dramatically increasing sample handling capacity and reducing labor intensity.
2Measurement precision
If SDS-PAGE/Western blotting is used to assay COMT protein concentration, then measurement precision is improved, but loss of substance increases due to neurotoxic and lung-irritant chemicals
Solution Approach 1:
The patent converts the harmful chemical system into a beneficial immunological system. Instead of using neurotoxic acrylamide, lung-irritant SDS, and other hazardous chemicals in SDS-PAGE, the ELISA method uses safe, non-hazardous reagents including enzyme-conjugated antibodies and chromogenic substrates. The measurement precision is maintained through the specific antibody-antigen binding and enzymatic amplification, while completely eliminating the harmful chemical exposure associated with traditional methods.
3Measurement precision
If current COMT assay methods are used, then measurement precision is maintained, but ease of operation deteriorates due to labor-intensive procedures
Solution Approach 1:
The ELISA assay employs self-service characteristics through enzyme-linked detection systems. The enzyme-conjugated antibodies automatically produce a color signal upon binding to the COMT protein and adding substrate, eliminating the need for complex detection procedures, radioactive isotopes, or sophisticated instrumentation. The assay is performed in standard microtiter plates using simple incubation and colorimetric reading, making it easily operable while maintaining precision.
4Measurement precision
If SDS-PAGE/Western blotting is used, then measurement precision is improved, but loss of time increases due to time-consuming procedures
Solution Approach 1:
The ELISA method enables continuous processing of multiple samples in parallel within the same assay run. The colorimetric detection allows for rapid, simultaneous measurement of COMT protein in numerous samples without the sequential steps required by SDS-PAGE and Western blots. The assay can be performed continuously from sample addition to final reading, dramatically reducing the time required per sample while maintaining measurement precision through standardized incubation and detection protocols.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The ELISA method provides a cost-effective, high-capacity, and safe means to assess COMT protein levels, enabling efficient screening for estrogenic endocrine disruptors and reducing the need for hazardous chemicals, thus addressing the limitations of existing assays.
Implementation Method 1
A novel enzyme-linked immunosorbent assay (ELISA) method using a unique 18-amino acid peptide sequence (Novel Epitope, NE) as a tag for protein detection, with specific antibodies
Implementation Method 2
enzyme-linked immunosorbent assay (ELISA) method using a unique 18-amino acid peptide sequence (Novel Epitope, NE) as a tag for protein detection
Data Source
AI summary
Disclosed is an assay (method) to quantify the amounts of catecholamine-O-methyltransferase (COMT) protein in samples, such as extracts from cell cultures, body fluids, tissues, and environmental samples. It uses novel agents (anti-NE, COMT-NE, or COMT-epitope-NE) in combination with two previously described agents (anti-COMT and COMT) in a competitive ELISA system to achieve this aim.